Published in

BioMed Central, Alzheimer's Research and Therapy, 1(7), 2015

DOI: 10.1186/s13195-015-0119-0

Links

Tools

Export citation

Search in Google Scholar

A phase Ib multiple ascending dose study of the safety, tolerability, and central nervous system availability of AZD0530 (saracatinib) in Alzheimer’s disease

Journal article published in 2015 by Haakon B. Nygaard, Allison F. Wagner, Garrett S. Bowen, Susan P. Good, Martha G. MacAvoy, Kurt A. Strittmatter, Adam C. Kaufman, Brian J. Rosenberg, Tomoko Sekine-Konno, Pradeep Varma, Kewei Chen, Anthony J. Koleske, Eric M. Reiman, Stephen M. Strittmatter ORCID, Christopher H. van Dyck
This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Upload
Green circle
Postprint: archiving allowed
Upload
Green circle
Published version: archiving allowed
Upload
Policy details
Data provided by SHERPA/RoMEO